Related Experiment Video

Updated: Jun 2, 2026

Co-Culture In Vitro Systems to Reproduce the Cancer-Immunity Cycle
12:19

Co-Culture In Vitro Systems to Reproduce the Cancer-Immunity Cycle

Published on: June 7, 2024

The reciprocal interaction: chemotherapy and tumor microenvironment

Soo-Hyun Kim1, Hyo-Jeong Kuh, Crispin R Dass

  • 1Department of Biomedical Sciences, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Current Drug Discovery Technologies
|April 26, 2011
PubMed

Insights

Drug penetration into solid tumors is hindered by the tumor microenvironment. Modifying this environment or using 3D culture systems may improve cancer drug delivery and efficacy.

Area of Science:

  • Oncology
  • Cancer Biology
  • Drug Delivery

Background:

  • Despite advances in cancer treatment, many patients succumb to the disease.
  • Limited drug penetration into solid tumors is a key challenge in cancer therapy.
  • Research has primarily focused on cellular drug resistance, neglecting drug distribution within tumor tissues.

Purpose of the Study:

  • To review the tumor microenvironment factors impeding drug penetration in solid tumors.
  • To explore if modulating the tumor microenvironment can enhance drug delivery.
  • To introduce in vitro 3D multicellular models for studying drug penetration.

Main Methods:

  • Literature review focusing on tumor microenvironment and drug penetration.
  • Analysis of studies investigating strategies to alter the tumor microenvironment.
  • Discussion of the utility of 3D multicellular culture systems.

Main Results:

  • The tumor microenvironment significantly obstructs drug penetration and distribution.
  • Specific microenvironmental factors are identified as barriers to drug delivery.
  • In vitro 3D models show promise in mimicking in vivo tumor characteristics for drug studies.

Conclusions:

  • The tumor microenvironment is a critical determinant of therapeutic efficacy.
  • Targeting the tumor microenvironment represents a potential strategy to improve cancer drug penetration.
  • Advanced in vitro models are essential for effective preclinical evaluation of drug delivery systems.

More Related Videos

A Proximal Culture Method to Study Paracrine Signaling Between Cells08:17

A Proximal Culture Method to Study Paracrine Signaling Between Cells

Published on: August 28, 2018

In Vitro Assay to Study Tumor-macrophage Interaction08:36

In Vitro Assay to Study Tumor-macrophage Interaction

Published on: August 1, 2019

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...